World Drug Delivery and Formulation 2011
17th - 18th January 2011
Maritim ProArte Hotel Berlin, Germany
Aizant Details
Aizant
Company Profile: Aizant is an integrated drug development solutions provider helping partners improve health care and quality of life through science, innovation and built in quality. We offer comprehensive solutions for Pre-formulation, Formulation Development, Analytical Development, cGMP Scale-up, Stability, Bioavailability, Bioequivalence, Phase I – Phase IV, Bio analytical and Diagnostics. At Aizant quality is built into all stages of drug development with an in-depth understanding of the product, process and the associated risks.
Key Products:
Dosage form Development
Our formulation laboratories are fully equipped to work on new chemical entities (NCEs), generics, speciality products, reformulation and life cycle extension of existing molecules. We have the expertise for developing robust formulations for molecules that have solubility, bioavailability and stability concerns.
Stability testing
We offer complete stability testing programs on pharmaceutically relevant compounds including APIs, pilot-formulation, packaging changes, drug development, customer manufactured products and clinical trial supplies on all storage conditions.
Manufacturing
We provide manufacturing support for all your clinical supply needs from Phase I to Phase III studies. Preparation and coordination of Chemistry, Manufacturing and Controls (CMC) documentation for worldwide regulatory submissions.
Clinical Research
Our clinical research is capable of handling all types of bioavailability (BA)/ bioequivalence (BE) studies, in healthy human volunteers. As per international conference on harmonization (ICH) and good clinical practice (GCP) guidelines.
Bioanalytical services
We offer extensive Bioanalytical services from discovery through phase IV.
Website:
www.aizant.com
